The FDA recommends that those with a BMI (body mass index) of 27 kg/m2 (or greater), and who exhibit one or more weight-related medical conditions, are eligible for Semaglutide GLP-1 treatment
Stay informed about emerging research and discuss these options with your healthcare provider
Its clear these medications are expensive, and their long-term health effects and side-effect profiles are still emerging in clinical trials
This lifts the fatty layer away from muscle
This article delves into what Semaglutide is, how it works, and how it can assist you in your weight loss journey
Prof John Deanfield, the director of the National Institute for Cardiovascular Outcomes Research and the lead author of the study, said the findings showed that the medication should be routinely prescribed to treat cardiovascular illnesses, and that millions of people across the UK could be taking the medication in the next few years